Global In-Vitro Diagnostics Market Size, Share | Industry Trends By 2027

Posted by mahesh on September 29th, 2022

Global In-Vitro Diagnostics Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period.

In terms of product & services, the in-vitro diagnostics market is segmented into instruments, reagents & kits, and software & services. In 2019, the reagents & kits segment held a largest market share of the in-vitro diagnostics market. This segment is also expected to dominate the market during the forecast period owing to increasing number of diagnostics tests and rising prevalence of chronic conditions. Moreover, the instruments segment is anticipated to witness considerable growth rate during the forecast period. Certain factors, such as developing healthcare infrastructure and growing demand for rapid disease diagnosis, are expected to drive the segment.


 The global in-vitro diagnostics market was assessed at US$ 65,093.13 million in 2018 and is speculated to generate US$ 107,658.83 million by 2027, it is expanding at a record annual growth rate of 5.8% during 2019–2027.


Increasing prevalence of chronic and infectious diseases, growing geriatric population, and rising demand for in-vitro diagnostics during COVID-19 pandemic are driving the market. However, the lack of healthcare infrastructure and reimbursement policies is likely to have a negative impact on the growth of the market in the coming years.


Request Sample PDF Brochure of Global In-Vitro Diagnostics Market Size, Global Analysis with Strategic Developments at:

Top Listed Companies in Global In-Vitro Diagnostics Market are –

  •          Abbott(US)
  •          F. Hoffmann-La Roche Ltd (Switzerland)
  •          Sysmex Corporation (Japan)
  •          Thermo Fisher Scientific Inc (US)
  •          Siemens AG (Germany)
  •          Danaher(US)
  •          bioMerieux SA (France)
  •          BD (US)
  •          QIAGEN (Netherland)

A thoroughgoing evaluation of the market restrains included in the report which represents the difference to drivers of the market and gives scope for strategic insights and developments. The research study has amalgamated the growth analysis of different aspects that enhance the market growth scenario. It constitutes key market drivers, restraints and trends that transform the market in either a positive or negative manner.

The Global In-Vitro Diagnostics Market Company Profiles are individually represented for all major participants and indices such as Financial Performance, Strategic Initiatives, Product Portfolio & Company Overview.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us :
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi


Phone: +1-646-491-9876

Like it? Share it!


About the Author

Joined: September 20th, 2022
Articles Posted: 71

More by this author